Minute Insight: Tasso Raises $100M In Series B To Scale Manufacturing Of At-Home Blood Collection Devices
Executive Summary
Tasso, which developed devices that allow patients to draw blood samples at home, wants to transform health care by supporting decentralized clinical trials, clinical research and remote patient health monitoring.
You may also be interested in...
Tasso Launches At-Home Blood Draw Platform For Trial Pre-Screening
Tasso has launched Tasso Care, a “scalable” blood data collection platform built around its unique at-home blood collection kit and screening data system.
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.